Researchers showed that an experimental therapy indirectly converted suppressive immune cells into tumor-fighting cells. This ...
Being able to rapidly reprogram Angry Kitten pods remotely based on the real-time threat environment would be hugely valuable ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...
Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced positive data from its HT-VA study, conducted under its Cooperative Research and Development ...
A single-atom nanozyme mimicking cytochrome c oxidase restores mitochondrial energy production in stem cells, shifting their ...
In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...
Market · GlobeNewswire Inc. The induced pluripotent stem cell (iPSC) market is experiencing robust growth, with a projected ...
Gear Patrol on MSN
Rolex’s Most Underrated Sports Watch Line Now Has a New Crown Jewel
With a new movement, redesigned bezel, and cleaner dial, the Yacht-Master II keeps its core calling cards while refining its ...
Researchers say knowing that semaglutide improves liver health independently of weight loss could influence prescribing decisions.
Ferrocene-modified covalent organic frameworks combine sonodynamic therapy with immune activation to suppress primary breast ...
Breast cancer remains one of the most common malignancies in women worldwide, and although overall survival has improved in recent decades, metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results